8-KThe WireRoutine
Bylaw Amendment
Filed Feb 7, 2023 · 3y ago · Accession 0001628280-23-002496
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Aquestive Therapeutics, Inc.
- Ticker
- AQST
- CIK
- 1398733
- Form type
- 8-K
- Filing date
- Feb 7, 2023
- Report date
- Feb 2, 2023
- Document
- aqst-20230202.htm
- Size
- 5.9 MB